Strategies to close the "mortality gap"

American Journal of Psychiatry

Volumn 167, Issue 2, 2010, Pages 120-121

  Flaum, Michael ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT;

ALCOHOL ABUSE; CLINICAL EVALUATION; COMORBIDITY; CONVALESCENCE; DIABETES MELLITUS; DRUG ABUSE; DRUG EFFECT; EDITORIAL; EMPHYSEMA; FOLLOW UP; HYPERLIPIDEMIA; HYPERTENSION; INFECTION; LIFE EXPECTANCY; MEDICAL CARE; MENTAL DISEASE; MENTAL HEALTH CARE; METABOLIC DISORDER; MORTALITY; OUTCOME ASSESSMENT; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PUBLIC HEALTH; QUALITY OF LIFE; SCIENTIFIC LITERATURE; SHORT FORM 36; SUICIDE; VASCULAR DISEASE;

ANTIPSYCHOTIC AGENTS; HUMANS; MENTAL DISORDERS; METABOLIC SYNDROME X; PREVENTIVE MEDICINE;

EID: 75749130731     PISSN: 0002953X     EISSN: 15357228     Source Type: Journal    
DOI: 10.1176/appi.ajp.2009.09111661     Document Type: Editorial

References (3)

1. Druss BG, von Esenwein SA, Compton MT, Rask KJ, Zhao L, Parker RM: A randomized trial of medical care management for community mental health settings: the Primary Care, Access, Referral, and Evaluation (PCARE) study. Am J Psychiatry 2009; 166:151-159
2. Saha S, Chant D, McGrath J: A systematic review of mortality in schizophrenia. Is the differential mortality gap worsening over time? Arch Gen Psychiatry 2007; 64:1123-1131
3. Rollnick S, Miller WR, Butler CC: Motivational Interviewing in Health Care: Helping Patients Change Behavior. New York, Guilford, 2008